Another Acquisition for Takeda; Buying URL Pharma for $800M

Four months after acquiring Intellikine Inc. for $320 million, and less than a year after its major purchase of Nycomed GmbH for $13.7 billion, Takeda Pharmaceutical Co. Ltd. said it will add another new asset to its portfolio.